Lazard Ltd Stock Price, News & Analysis

Lazard (NYSE: LAZ) reported preliminary assets under management (AUM) of $264.5 billion as of September 30, 2025. The month included $5.4 billion of market appreciation, $0.5 billion of FX appreciation, and $0.3 billion of net inflows. Preliminary average AUM for the quarter ended September 30, 2025 was $257.4 billion.

Segment AUM (Sept 30, 2025): Equity $208.5 billion; Fixed Income $47.2 billion; Other $8.8 billion; Total AUM $264.537 billion. August 31, 2025 total AUM was $258.368 billion. All figures are unaudited and preliminary, subject to adjustment.

Lazard (NYSE: LAZ) will release third quarter and nine month 2025 financial results on Thursday, October 23, 2025. The press release will be posted in the News & Announcements section at www.lazard.com. Lazard will host a conference call to discuss results on October 23, 2025 at 8:00 a.m. ET, accessible via a live audio webcast in the Investor Relations section of www.lazard.com or by phone using conference ID LAZQ325. A replay will be available by 10:00 a.m. ET on October 23, 2025 through the Investor Relations site or by toll-free replay numbers for U.S./Canada and international callers.

Lazard Listed Infrastructure ETF (NYSE Arca: GLIX) launched on October 6, 2025, offering an actively managed equity strategy that targets listed infrastructure companies.

GLIX holds a concentrated portfolio of 25–50 companies with market caps above $2 billion, emphasizes inflation‑linked, monopoly‑like cash flows, uses a benchmark‑aware, bottom‑up process, and is passively hedged to USD for U.S. investors. The strategy is managed by Bertrand Cliquet, Matthew Landy, John Mulquiney, and Warryn Robertson and positions infrastructure as a middle ground between equities and fixed income.

Lazard (NYSE: LAZ) announced on October 3, 2025 that Retired Four‑Star U.S. Army General Michael “Erik” Kurilla has joined as Senior Advisor in Lazard’s Geopolitical Advisory group, effective immediately.

Kurilla brings strategic command experience in the Middle East and Central Asia. The hire builds on Lazard Geopolitical Advisory, launched three years ago, to advise clients on the intersection of geopolitics, policy, and investment strategy. Lazard CEO Peter Orszag and General Kurilla both emphasized the role of geopolitics in shaping market and business decisions.

Lazard (NYSE:LAZ) has announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London. Cotte joins from Evercore, where he served as Partner and Senior Managing Director in the European Financial Institutions Group.

With over 20 years of experience, Cotte brings extensive expertise in advising insurers and financial institutions on major transactions. His track record includes notable deals such as Allianz's acquisition of Viridium, Athora's Irish Life business sale, and MetLife's UK Pension Risk Transfer business divestment.

Prior to Evercore, Cotte held senior positions at Citi's EMEA Financial Institutions Group, Macquarie, Fox-Pitt Kelton, and EY. He holds a Master's in Management from EDHEC Business School.

Lazard Global Total Return and Income Fund (NYSE:LGI) has declared its monthly distribution of $0.14646 per share, payable on October 22, 2025, to shareholders of record on October 10, 2025. The distribution breakdown includes 10% from net income, 90% from capital gains, and no return of capital for the current distribution.

The Fund reported notable performance metrics, including a 8.71% average annual total return over the 5-year period and a 9.73% annualized distribution rate. The Fund's portfolio consists of 60-80 US and non-US equity securities, with investments in companies having market capitalizations above $2 billion, including emerging markets exposure. As of August 31, 2025, Lazard Asset Management managed $258.4 billion in client assets.

Lazard (NYSE:LAZ) has announced the appointment of Dr. Geoffrey Porges as Managing Director in its Healthcare Advisory Group. Dr. Porges brings over 30 years of experience in the biopharmaceutical industry, most recently serving as EVP and CFO at Schrödinger.

Prior to Schrödinger, Dr. Porges held notable positions including head of biopharma equity research at SVB Leerink and senior biotechnology analyst at Sanford C. Bernstein. He also served in senior roles at BTG PLC and Merck & Co. Dr. Porges holds a medical degree from the University of Sydney and an MBA from Harvard Business School as a Baker Scholar.

Lazard (NYSE:LAZ) has announced a strategic expansion of its Nordic operations with the appointment of Jesper Jensen as Managing Director, Financial Advisory and CEO of Denmark, effective September 17, 2025. The company is establishing a new office in Denmark as part of this expansion.

Jensen brings over 25 years of experience and will work closely with Gustaf Slettengren and Victor Kastensson in Sweden to strengthen Lazard's presence in the Nordic region. He joins from Rothschild & Co and previously worked at JP Morgan in London. The appointment aligns with Lazard's 2030 strategic plan and aims to enhance the firm's ability to deliver global financial solutions to Nordic clients.

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of $258.4 billion for August 2025. The month saw market appreciation of $2.7 billion and FX appreciation of $2.2 billion, partially offset by net outflows of $0.2 billion.

The AUM breakdown includes $202.5 billion in Equity, $46.9 billion in Fixed Income, and $9.0 billion in Other assets. These figures represent increases across all categories compared to July 2025 levels.